| Article
Newswise — Migraine headache is the third most common disease in the world affecting about 1 in 7 people. More prevalent than diabetes, epilepsy and asthma combined, migraine headaches are among the most common and potentially debilitating disorders encountered by primary health care providers....
| Article
What a person experiences during a migraine, loosely speaking, is a very sensitized brain. Migraine is among the most disabling disorders in the world, and much of the treatment armamentarium to date comes with significant unwanted effects. But new advances in our understanding of neurotransmitters...
| Article
Newswise — Inhaled cannabis reduces self-reported headache severity by 47.3% and migraine severity by 49.6%, according to a recent study led by Carrie Cuttler, a Washington State University assistant professor of psychology.
The study, published online recently in the Journal of Pain, is the first...
| Video
Women and migraines. What’s new in research? Meredith Barad, MD, discusses where we are now in the study of migraine in women.
| Article
A study published in Neurology evaluated facial pain presentation from an outpatient clinic in Germany. Headache and facial pain patients completed questionnaires. “Based on these findings, researchers believe that these symptoms could be a facial pain disorder that is not yet well described or...
| Article
Newswise — As research continues to show progress towards minimizing the effects of headache disorders on patients’ lives, Practical Neurology® gathered insights from experts in the field at The American Headache Society (AHS) 61stAnnual Scientific Meeting this year, where new data looking at a...
| Article
Newswise — Clarksville resident Hope Dyer remembers the day she looked out a window, saw it was raining and immediately began crying. She realized it was the first time in more than two decades that a drop in barometric pressure before a storm hadn’t triggered a debilitating migraine.
In November...
| Article
Newswise — An increasing number of Americans are using opioids to treat their migraine headaches, despite the fact that opioids are not the recommended first-line therapy for migraine in most cases. That’s according to the ObserVational Survey of the Epidemiology, tReatment and Care Of MigrainE...
| Article
American Headache Society: Chronic Migraine Education Program
Developed by the American Headache Society, the Chronic Migraine Education Program (CMEP) includes new advances and addresses acute and preventive treatment options. In addition...
Listen to part 1 of the podcast
Part 1 will...